202 related articles for article (PubMed ID: 1904062)
1. Bryostatins selectively regulate protein kinase C-mediated effects on GH4 cell proliferation.
Mackanos EA; Pettit GR; Ramsdell JS
J Biol Chem; 1991 Jun; 266(17):11205-12. PubMed ID: 1904062
[TBL] [Abstract][Full Text] [Related]
2. Three activators of protein kinase C, bryostatins, dioleins, and phorbol esters, show differing specificities of action on GH4 pituitary cells.
Ramsdell JS; Pettit GR; Tashjian AH
J Biol Chem; 1986 Dec; 261(36):17073-80. PubMed ID: 3465727
[TBL] [Abstract][Full Text] [Related]
3. The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells.
Stanwell C; Gescher A; Bradshaw TD; Pettit GR
Int J Cancer; 1994 Feb; 56(4):585-92. PubMed ID: 8112895
[TBL] [Abstract][Full Text] [Related]
4. Bryostatin 1, an activator of protein kinase C, mimics as well as inhibits biological effects of the phorbol ester TPA in vivo and in vitro.
Gschwendt M; Fürstenberger G; Rose-John S; Rogers M; Kittstein W; Pettit GR; Herald CL; Marks F
Carcinogenesis; 1988 Apr; 9(4):555-62. PubMed ID: 2451575
[TBL] [Abstract][Full Text] [Related]
5. Different biological effects of the two protein kinase C activators bryostatin-1 and TPA on human carcinoma cell lines.
Steube KG; Grunicke D; Drexler HG
Invest New Drugs; 1994; 12(1):15-23. PubMed ID: 7960600
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of protein kinase C agonists on prostaglandin production and growth in human breast cancer cells.
Boorne AJ; Donnelly N; Schrey MP
Breast Cancer Res Treat; 1998 Mar; 48(2):117-24. PubMed ID: 9596483
[TBL] [Abstract][Full Text] [Related]
7. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.
Jalava AM; Heikkilä J; Akerlind G; Pettit GR; Akerman KE
Cancer Res; 1990 Jun; 50(11):3422-8. PubMed ID: 2334938
[TBL] [Abstract][Full Text] [Related]
8. Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-beta 1 genes in breast tumour cells.
Nutt JE; Harris AL; Lunec J
Br J Cancer; 1991 Oct; 64(4):671-6. PubMed ID: 1911215
[TBL] [Abstract][Full Text] [Related]
9. Effects of activators of protein kinase C, including bryostatins 1 and 2, on the growth of A549 human lung carcinoma cells.
Dale IL; Gescher A
Int J Cancer; 1989 Jan; 43(1):158-63. PubMed ID: 2910827
[TBL] [Abstract][Full Text] [Related]
10. Voltage-dependent calcium channels regulate GH4 pituitary cell proliferation at two stages of the cell cycle.
Ramsdell JS
J Cell Physiol; 1991 Feb; 146(2):197-206. PubMed ID: 1705563
[TBL] [Abstract][Full Text] [Related]
11. The effect of fetal calf serum on growth arrest caused by activators of protein kinase C.
Bradshaw TD; Gescher A; Pettit GR
Int J Cancer; 1991 Apr; 47(6):929-32. PubMed ID: 1707036
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
Kennedy MJ; Prestigiacomo LJ; Tyler G; May WS; Davidson NE
Cancer Res; 1992 Mar; 52(5):1278-83. PubMed ID: 1737390
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of bryostatins and phorbol esters on arachidonic acid metabolite release and epidermal growth factor binding in C3H 10T1/2 cells.
Dell'Aquila ML; Herald CL; Kamano Y; Pettit GR; Blumberg PM
Cancer Res; 1988 Jul; 48(13):3702-8. PubMed ID: 3132318
[TBL] [Abstract][Full Text] [Related]
14. Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells.
Dale IL; Bradshaw TD; Gescher A; Pettit GR
Cancer Res; 1989 Jun; 49(12):3242-5. PubMed ID: 2720677
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-alpha and -beta are potent and effective inhibitors of GH4 pituitary tumor cell proliferation.
Ramsdell JS
Endocrinology; 1991 Apr; 128(4):1981-90. PubMed ID: 2004614
[TBL] [Abstract][Full Text] [Related]
16. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
Vrana JA; Saunders AM; Chellappan SP; Grant S
Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391
[TBL] [Abstract][Full Text] [Related]
17. Partial parallelism and partial blockade by bryostatin 1 of effects of phorbol ester tumor promoters on primary mouse epidermal cells.
Sako T; Yuspa SH; Herald CL; Pettit GR; Blumberg PM
Cancer Res; 1987 Oct; 47(20):5445-50. PubMed ID: 2888531
[TBL] [Abstract][Full Text] [Related]
18. Modulation by staurosporine of phorbol-ester-induced effects on growth and protein kinase C localization in A549 human lung-carcinoma cells.
Bradshaw TD; Gescher A; Pettit GR
Int J Cancer; 1992 Apr; 51(1):144-8. PubMed ID: 1563835
[TBL] [Abstract][Full Text] [Related]
19. Bryostatins: potent, new mitogens that mimic phorbol ester tumor promoters.
Smith JB; Smith L; Pettit GR
Biochem Biophys Res Commun; 1985 Nov; 132(3):939-45. PubMed ID: 3907633
[TBL] [Abstract][Full Text] [Related]
20. Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin.
Hennings H; Blumberg PM; Pettit GR; Herald CL; Shores R; Yuspa SH
Carcinogenesis; 1987 Sep; 8(9):1343-6. PubMed ID: 3621472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
